Stay updated on SNDX-5613 in R/R Leukemias: Clinical Trial
Sign up to get notified when there's something new on the SNDX-5613 in R/R Leukemias: Clinical Trial page.

Latest updates to the SNDX-5613 in R/R Leukemias: Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov record for the revumenib study is now available, with details on the trial design, eligibility criteria, participating locations, and measured outcomes replacing the error page.SummaryDifference100%

- Check9 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA banner was added announcing NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision identifier also changed.SummaryDifference1%

- Check37 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page remains a 403 error screen.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access-denied message. As a result, the study details, related links, and contact/location information that were previously visible are no longer accessible.SummaryDifference22%

- Check58 days agoChange DetectedUI label updated from 'Find Contact Information' to 'Find contact information', and the page revision tag was updated from v3.6.6 to v3.7.0, representing a minor UI/metadata update rather than substantive study content.SummaryDifference0.0%

Stay in the know with updates to SNDX-5613 in R/R Leukemias: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-5613 in R/R Leukemias: Clinical Trial page.